An observational study in Pancreatitis, sponsored by Helios Albert-Schweitzer-Klinik Northeim. Status unknown at 3 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-12.
Sponsored by Helios Albert-Schweitzer-Klinik Northeim · Observational
Endoscopic ultrasonography (EUS ) -guided fine needle aspiration (EUS -FNA ) of focal pancreatic lesions is an essential diagnostic procedure with high therapeutic effect in clinical routine.
The aim of this study is to determine the levels of serum lipase, serum amylase and the tumor marker CA 19-9 prior and after EUS-FNA. In animal experiments on dogs, an increase of all three parameters was observed after surgery on the pancreas. For humans, these clinically important data are not yet available .
It is assumed that the probability of pancreatitis with increased activity of lipase and amylase will rise with the number of puncture procedures as well as the size of the puncture needle. In addition, the post-interventional assessment of the tumor marker CA 19-9 could result in a false positive assumption of malignant neoplastic pancreatic lesion.
752 studies on the registry are indexed under Pancreatitis; 181 are open to participants now.
This study's planned enrollment of 208 is above the median of 180 across 277 observational studies indexed under Pancreatitis.
Browse Pancreatitis studies →Helios Albert-Schweitzer-Klinik Northeim is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with independent indication for endoscopic ultrasound-guided fine needle aspiration of the pancreas due to pancreatic disease (e.g. pancreatitis, pancreatic masses) no volunteers accepted
Exclusion Criteria:
blood collection prior to fine needle aspiration Endoscopic ultrasonography-guided fine needle aspiration of the pancreas blood collection after to fine needle aspiration
Procedure: blood collection · Procedure: fine needle aspiration
blood will be taken for assessment of serum lipase, serum amylase and CA 19-9 prior to EUS-FNA
During endoscopic ultrasonography, fine needle aspiration will be performed for cytological analysis of the pancreas
blood will be taken 4h after EUS-FNA for assessment of serum lipase, serum amylase and CA 19-9
Serum lipase
Time frame: up to 24h prior to EUS-FNA and 4 hours after EUS-FNA
Serum amylase
Time frame: up to 24 hours prior to EUS-FNA
Serum amylase
Time frame: 4 hours after EUS-FNA
CA 19-9
Time frame: up to 24 hours prior to EUS-FNA
CA 19-9
Time frame: 4 hours after EUS-FNA
This study is status unknown, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Helios Albert-Schweitzer-Klinik Northeim